Previous Page  3 / 6 Next Page
Information
Show Menu
Previous Page 3 / 6 Next Page
Page Background

Page 7

Notes:

allied

academies

August 16-17, 2018 | Copenhagen, Denmark

Industrial Biotechnology and Bioprocessing

International Conference on

Journal of Archives of Industrial Biotechnology | Volume 2

F

ermBiotics and Fermentationexperts have developed

several fermented plant and seaweed products for

pigs, poultry and human health. The products consist of

prebiotics, probiotics and bioactives from the fermented

plant and seaweed material. We have demonstrated very

good in vitro anti-microbial and anti-inflammatory activities

of the fermented material. A pig trial shows that fermented

feed called EP100i containing fermented canola can replace

zinc oxide in pig’s feed. The European Commission (EC)

has voted in favour of a ban on the veterinary use of zinc

oxide in feed. An additional pig trial showed a high (58%)

reduction of LDL-cholesterol in pigs given 4 % EP100i feed

compared with normal feed. We have demonstrated

positive gut microbiome modulation in several animal

models. FermBiotics will in collaboration with Silkeborg

Hospital, Denmark in the EU project Macro Cascade run a

randomized double-blinded matched cross trial using a

dose of 5 g fermented canola and seaweed material. The

clinical trial will be performed in N=80 human patients with

mild-moderate state of Inflammatory Bowel Disease (IBD)

and/or Spondyloarthropathy (SPA) including both gender.

Speaker Biography

Søren Kjærulff is currently CEO of Fermbiotics and CTO of Fermentationexperts. He is

responsible for development of fermented plant and macroalgae food and feed products

with microbiome modulatory activity and for introducing the product to the market,

investigate and develop its functionality, identify the regulatory requirements, as well as

go-to-market strategies. He was the former senior director of biopharmaceuticals R&D

at Novozymes and responsible for anti-microbial and anti-inflammatory peptides and

albumin half-life extension of peptide drugs. He also served as the former vice president of

R&D at Pantheco and Santaris Pharma.

e:

sk@fermbiotics.com

Søren Kjærulff

FermBiotics, Denmark

Fermented canola and seaweed feed and food products – prebiotics, probiotics and

bioactives